drugset / Trial / NCT03490916

Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography

NCT03490916

Phase 4 Terminated 18 enrolled Vincent Kan
RandomizedParallel-groupTriple-blindTreatment

Summary

The overall goal of this study is to detect preclinical signs of HAPE by lung ultrasonography and evaluate the effectiveness of acetazolamide at decreasing pulmonary edema by using ultrasound.

Timeline

Start
2018-03-23
Primary completion
2018-04-04
Completion
2018-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 250 mg